Chemplast Sanmar (CHEMPLASTS) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
17 Dec, 2025Executive summary
FY25 consolidated revenue reached ₹4,346 crore, up 11% year-over-year, with EBITDA at ₹219 crore, a significant rise from ₹26 crore in FY24.
Net loss narrowed to ₹110 crore in FY25 from ₹158 crore in FY24, reflecting operational improvements despite persistent PVC industry headwinds.
Audited standalone and consolidated results for FY25 were approved with an unmodified opinion; no dividend was declared.
Specialty chemicals and custom manufacturing drove growth, while PVC segments faced margin pressure due to global oversupply and dumping.
Announced a greenfield capex of ₹340 crore for R32 refrigerant gas production, reinforcing growth in specialty chemicals.
Financial highlights
Q4 FY25 revenue was ₹1,151 crore, up 10% year-over-year; EBITDA for the quarter was ₹37 crore, up from ₹21 crore in Q4 FY24.
Specialty chemicals revenue grew 53% year-over-year to ₹1,764 crore for FY25; value-added chemicals revenue was ₹504 crore.
Suspension PVC revenue declined 6% year-over-year to ₹2,298 crore due to lower realizations and volumes.
Net cash from operating activities improved to ₹146 crore in FY25 from negative ₹225 crore in FY24.
Standalone revenue from operations for FY25 was ₹2,387.61 crore, up from ₹1,655.58 crore in FY24.
Outlook and guidance
Specialty chemicals expected to drive future growth, with the R-32 refrigerant project as a key initiative.
Management remains optimistic about improved pricing and demand revival in H2 FY26, especially if anti-dumping measures take effect.
Custom manufacturing business on track to exceed ₹1,000 crore revenue in FY27, with potential to surpass guidance.
Margins in specialty and suspension PVC expected to improve and sustain medium to long term due to global demand-supply tightness.
Latest events from Chemplast Sanmar
- Q3 FY26 saw losses and revenue decline, but capacity expansions and regulatory shifts support recovery.CHEMPLASTS
Q3 25/269 Feb 2026 - Q1 FY25 delivered strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/252 Feb 2026 - Revenue and EBITDA rose, but net losses deepened amid margin and regulatory pressures.CHEMPLASTS
Q2 25/2619 Dec 2025 - H1 FY25 revenue up 8% YoY; Q2 margins fell, but anti-dumping duties and tax changes aid outlook.CHEMPLASTS
Q2 24/2519 Dec 2025 - Revenue and EBITDA rose, losses narrowed, but margin pressures from dumping persist.CHEMPLASTS
Q3 24/2519 Dec 2025 - Q1 FY26 saw a 4% revenue drop, INR 64 crore net loss, and one-time revaluation impacts.CHEMPLASTS
Q1 25/2619 Dec 2025